Company profile: The Dedham Group
1.1 - Company Overview
Company description
- Provider of management and strategic consulting, offering digital health innovation strategies (opportunity assessments, go-to-market, product development), urology channel strategy (market penetration, risk evaluation, contracting, account prioritization), PULSE Analytics to pinpoint oncology decision-makers, patient support program solutions, and clinical pathways strategy.
Products and services
- PULSE Analytics: Analytics-driven system that identifies key oncology decision-makers and analyzes their influence, producing actionable insights to architect optimized engagement strategies across targeted stakeholders
- Digital Health Innovations: Market-focused advisory that delivers strategic insights for digital health engagement, conducting opportunity assessments, crafting go-to-market strategies, and guiding product development for pharmaceutical manufacturers and digital health innovators
- Clinical Pathways Strategy: Strategy-focused service that supplies strategic advice on clinical pathways to improve market access and operational planning
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to The Dedham Group
Almac
HQ: United Kingdom
Website
- Description: Provider of contract development and manufacturing services to pharmaceutical and biotech companies globally, including R&D, biomarker discovery and development, API manufacture, formulation development, clinical trial supply, and IXRS technology. Offers genomic services, clinical trial assays, companion diagnostics, PD biomarker testing, CDx manufacturing, and the claraT software.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Almac company profile →
US Pharma Lab
HQ: United States
Website
- Description: Provider of custom development, manufacturing, and supply services for premium dietary supplement ingredients, premixes, and products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full US Pharma Lab company profile →
BioAgilytix
HQ: United States
Website
- Description: Provider of bioanalytical lab services specializing in immunoassays and cell-based assays, based in Research Triangle Park, NC. Offers custom assay development (de novo, partial, cross-matrix, GxP validations), method transfer, preclinical and clinical sample analysis, specimen collection kit support, off-the-shelf assays, and biomedical diagnostic testing for infectious diseases, diagnostic immunology, vitamin and parasite-borne infections, and LDTs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioAgilytix company profile →
Snapdragon Chemistry
HQ: United States
Website
- Description: Provider of practical manufacturing solutions for challenging chemical transformations, including API process development, GMP drug substance manufacturing in-house or at Cambrex’s global sites, proprietary continuous process technologies, reactor build and design with 3D CAD and custom components, portfolio optimization, and complex synthetics such as block copolymers, polymeric linkers, and functionalized dendrimers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Snapdragon Chemistry company profile →
Dottikon ES
HQ: Switzerland
Website
- Description: Provider of chemicals, intermediates, and active pharmaceutical ingredients for chemical, biotech, and pharmaceutical industries; cGMP API manufacturing; process development (R&D, routefinding, process design); small-, pilot-, and large-scale production with expertise in hazardous reactions and high-potency products; project and quality management; recycling and waste treatment including thermal recovery and waste water treatment and purification.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Dottikon ES company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for The Dedham Group
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to The Dedham Group
2.2 - Growth funds investing in similar companies to The Dedham Group
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for The Dedham Group
4.2 - Public trading comparable groups for The Dedham Group
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →